gentamicin c1a has been researched along with linezolid in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 5 (55.56) | 2.80 |
Authors | Studies |
---|---|
Brozovic, A; Dowson, CG; Gazvoda, M; KoĊĦmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Kulkarni, MR; Lad, NP; Manohar, Y; Mascarenhas, M; Pandit, SS; Pandit, YB; Salkar, K; Sharma, R; Suthar, A | 1 |
Guo, H | 1 |
Abutaleb, NS; Elsebaei, MM; Hagras, M; Li, D; Mahgoub, AA; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
Abutaleb, NS; Alhashimi, M; Elsebaei, MM; Elzahabi, HS; Hosny, Y; Mayhoub, AS; Omara, M; Seleem, MN | 1 |
Abouzid, KAM; Abutaleb, NS; Al-Karaki, R; Dokla, EME; El-Baz, K; Klein, CD; Li, D; Milik, SN; Nasr, M; Seleem, MN; Shalaby, MW | 1 |
Abutaleb, NS; Hagras, M; Kotb, A; Mayhoub, AS; Salama, EA; Sayed, AM; Seleem, MN | 1 |
Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
1 review(s) available for gentamicin c1a and linezolid
Article | Year |
---|---|
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
8 other study(ies) available for gentamicin c1a and linezolid
Article | Year |
---|---|
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Fungi; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure | 2017 |
Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.
Topics: Amines; Animals; Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Macrophages; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Obesity; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2019 |
Modifying the lipophilic part of phenylthiazole antibiotics to control their drug-likeness.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Macrophages; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats; Rats, Sprague-Dawley; Staphylococcus; Structure-Activity Relationship; Thiazoles | 2020 |
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria.
Topics: Anti-Bacterial Agents; Benzimidazoles; Colistin; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2020 |
Oxadiazolylthiazoles as novel and selective antifungal agents.
Topics: Antifungal Agents; Aspergillus; Biofilms; Caco-2 Cells; Candida; Cryptococcus; Humans; Microbial Sensitivity Tests; Oxadiazoles; Stereoisomerism; Thiazoles | 2020 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |